Clinical Trials
Prestige Biopharma IDC Files Patent For Next Generation Subcutaneous Antibody Delivery Platform
Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation ...
April 24, 2026 | News
NOVI Health Study Shows Integrated GLP One And Digital Coaching Achieve Clinical Grade Weight Loss Outcomes
An estimated ~14.7% weight loss at 18 months was achieved in one of the first studies evaluating integrated GLP-1 therapies and di...
April 23, 2026 | News
Dayspring Pharma Reports Positive Phase II Results For CG2001 In Androgenetic Alopecia
Dayspring Pharma announced top-line data from its Phase II clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial ...
April 23, 2026 | News
Leinco Technologies And CellCarta Partner To Advance Proteomics In Immuno Oncology
Leinco Technologies, a leader in antibody and protein development, and CellCarta, a global provider of precision medicine laboratory services, are ple...
April 22, 2026 | News
Datasea Delivers AI Multimodal Projects Worth RMB 6.9 Million To Accelerate High Margin Shift
Completed Projects Further Support the Company's Transition Toward High-Margin, Solution-Driven Revenue and Strengthen Customer Stickiness Across AI Multim...
April 22, 2026 | News
Mabwell Secures JFDA GMP Compliance For Denosumab Biosimilars, Marking PIC S Milestone
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-m...
April 22, 2026 | News
Akamis Bio Reports Promising Early Efficacy For NG 350A In Rectal Cancer Study
NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...
April 21, 2026 | News
EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study
First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...
April 21, 2026 | News
Samsung Bioepis Initiates Phase 1 Clinical Trial for Novel ADC Candidate SBE303 Targeting Nectin 4
Samsung Bioepis Co., Ltd. announced the initiation of a Phase 1 clinical trial for SBE303, its first novel antibody drug conjugate candidate designed...
April 16, 2026 | News
Hoth Therapeutics Reports Positive HT VA Study Data Highlighting GDNF Driven Metabolic Reprogramming In Fatty Liver Disease
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, announced positive data from its HT-VA study, conducted unde...
April 15, 2026 | News
Caliway Secures Third Aesthetic Surgery Journal Recognition For CBL 514 Phase 2b Fat Reduction Study
Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the...
April 15, 2026 | News
Thermo Fisher Scientific Partners HealthVerity To Advance Data Driven Clinical Development
Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) ...
April 14, 2026 | News
DualityBio Secures NMPA Review For Trastuzumab Pamirtecan In HER2 Positive Breast Cancer
DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", ...
April 14, 2026 | News
AnBogen Therapeutics Showcases Imofinostat Breakthroughs At AACR Annual Meeting 2026
AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, announced that two key research abstracts regarding its lead co...
April 14, 2026 | Report
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
